PAC and Hemodynamic Monitoring 2-4-08
Transcript of PAC and Hemodynamic Monitoring 2-4-08
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
1/32
Pulmonary Artery CathetersPulmonary Artery Catheters
and Hemodynamic Monitoringand Hemodynamic Monitoring
byby
Joseph Esherick, M.D., FAAFPJoseph Esherick, M.D., FAAFP
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
2/32
JAMA. 2005; 294: 1664JAMA. 2005; 294: 1664--70.70.
13 RCTs13 RCTs
5051 patients analyzed5051 patients analyzed
Surgical patients, ARDS, Sepsis and advanced CHFSurgical patients, ARDS, Sepsis and advanced CHF
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
3/32
22
Shock EquationsShock Equations
Definition of shockDefinition of shock
A medical condition in which tissue perfusion andA medical condition in which tissue perfusion andoxygen delivery is insufficient for the metabolic demandsoxygen delivery is insufficient for the metabolic demandsof the body.of the body.
In shock, there is an imbalance between oxygenIn shock, there is an imbalance between oxygendelivery to tissues and oxygen consumption by tissuesdelivery to tissues and oxygen consumption by tissues
Oxygen delivery (DOOxygen delivery (DO22))
DODO22== cc (Hgb)(CO)(SaO(Hgb)(CO)(SaO22)) Oxygen consumption (VOOxygen consumption (VO22))
VO2= c (Hgb)(CO)(SaO2-SvO2)
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
4/32
33
Hemodynamic PrinciplesHemodynamic Principles
CO is theholy grail ofhemodynamics
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
5/32
44
Basic HemodynamicsBasic Hemodynamics
CO = HR XSV
RAP
Volume
CVP RVEDP
PAPPCWPPVP
LAP
LVEDP
LVEDV
RVEDVI
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
6/32
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
7/32
66
Indications for PulmonaryIndications for Pulmonary
Artery Catheters (PACs)Artery Catheters (PACs) Assessment of shock statesAssessment of shock states
Assessment of pulmonary edema (cardiogenic vs ARDS)Assessment of pulmonary edema (cardiogenic vs ARDS)
Guidance of therapy with combined oliguria or hypotensionGuidance of therapy with combined oliguria or hypotensionand pulmonary edemaand pulmonary edema
Optimization of cardiac index in cardiogenic shockOptimization of cardiac index in cardiogenic shock
Evaluation and drug titration for severe pulmonaryEvaluation and drug titration for severe pulmonaryhypertensionhypertension
Diagnostic evaluation of leftDiagnostic evaluation of left--toto--right cardiac shuntsright cardiac shunts
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
8/32
77
Relative ContraindicationsRelative Contraindications
of PACsof PACs
Severe coagulopathy or thrombocytenia (PLT < 50K)Severe coagulopathy or thrombocytenia (PLT < 50K)
Prosthetic right heart valveProsthetic right heart valve
Endocardial pacemaker/ defibrillatorEndocardial pacemaker/ defibrillator
Caution with LBBB (5% risk of complete heart block)Caution with LBBB (5% risk of complete heart block)
RightRight--sided Endocarditissided Endocarditis
Uncontrolled ventricular or atrial dysrhythmiasUncontrolled ventricular or atrial dysrhythmias
Right ventricular mural thrombusRight ventricular mural thrombus
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
9/32
88
Complications of PACsComplications of PACs
Complications from cordis catheter placementComplications from cordis catheter placement PneumothoraxPneumothorax
Arterial punctureArterial puncture
Air embolusAir embolus
Atrial or ventricular dysrhythmiasAtrial or ventricular dysrhythmias RBBB (0.1RBBB (0.1-- 5% of insertions)5% of insertions)
Pulmonary infarctionPulmonary infarction
Pulmonary artery rupture (0.2% incidence, leave balloon inflated)Pulmonary artery rupture (0.2% incidence, leave balloon inflated)
CatheterCatheter--related blood stream infectionrelated blood stream infection Marantic or infectious endocarditisMarantic or infectious endocarditis
Mural thrombusMural thrombus
Knotting of catheterKnotting of catheter
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
10/32
99
Normal Hemodynamic ValuesNormal Hemodynamic Values
CategoryCategory Normal rangeNormal range InterpretationInterpretation
Cardiac output (CO)Cardiac output (CO) 44--8L/min.8L/min. CI is more acc urateCI is more accurate
Cardiac index (CI)Cardiac index (CI) 2.52.5--4.0L/min.4.0L/min. C O adjusted for body surface areaCO adjusted for body surface area
Systemic vascularSystemic vascular
resistance (SVR)resistance (SVR)
900900--13001300
dynes/cmdynes/cm22Calculated value systemicSBP and COCalculated value systemicSBP and CO
SVRISVRI 19701970--23902390
dynes/cmdynes/cm22SVR adjusted for body surface areaSVR adjusted for body surface area
Pulmonary vascularPulmonary vascular
resistance (PVR)resistance (PVR)
100100--250250
dynes/cmdynes/cm22Elevated in pulmonary hypertension, acute PE,Elevated in pulmonary hypertension, acute PE,
hypercapnia and hypoxemiahypercapnia and hypoxemia
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
11/32
1010
Cardiac Index
(Thermodilution Technique)
Conditions causing a high Cardiac IndexConditions causing a high Cardiac Index
Cirrhosis, Thyrotoxicosis, AV fistula, Beriberi, PregnancyCirrhosis, Thyrotoxicosis, AV fistula, Beriberi, Pregnancy
Fever, activity and delirium tremensFever, activity and delirium tremens
Distributive shockDistributive shock
Conditions causing a low Cardiac IndexConditions causing a low Cardiac Index
Cardiogenic shock, tension pneumothorax, cardiac tamponade, andCardiogenic shock, tension pneumothorax, cardiac tamponade, and
massive PEmassive PE
High PEEPHigh PEEP
HypovolemiaHypovolemia
Falsely low: Severe TR/PI or VSDFalsely low: Severe TR/PI or VSD
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
12/32
1111
Hemodynamic PrinciplesHemodynamic Principles
CVP = RAP = RV preloadCVP = RAP = RV preload
PCWP = pulmonary venous pressure = left atrial pressurePCWP = pulmonary venous pressure = left atrial pressureapproximatingapproximating LVEDP = LV preloadLVEDP = LV preload
Read the PCWP at the Z point at endRead the PCWP at the Z point at end--expirationexpiration Z point is 0.08seconds after the QRScomplexZ point is 0.08seconds after the QRScomplex
Cardiogenic pulmonary edema excluded if PCWP 18mmHgCardiogenic pulmonary edema excluded if PCWP 18mmHg
PAD = PCWP (in most circumstances)PAD = PCWP (in most circumstances)
PAD > PCWPPAD > PCWP with pulmonary hypertension, cor pulmonale, acutewith pulmonary hypertension, cor pulmonale, acutepulmonary embolus, pulmonary venoocclusive disease andpulmonary embolus, pulmonary venoocclusive disease andEisenmengers syndromeEisenmengers syndrome
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
13/32
1212
Systemic Vascular ResistanceSystemic Vascular Resistance
Conditions associated with high SVRIConditions associated with high SVRI
Cardiogenic shockCardiogenic shock
HypovolemiaHypovolemia
Obstructive shockObstructive shock
Conditions associated with a lowSVRIConditions associated with a lowSVRI
Distributive shockDistributive shock
CirrhosisCirrhosis
PregnancyPregnancy
ThyrotoxicosisThyrotoxicosis
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
14/32
1313
CVP and PCWPCVP and PCWP
Conditions that Increase CVPConditions that Increase CVP
RV infarctRV infarct
Severe tricuspid valve diseaseSevere tricuspid valve disease
Cardiac tamponadeCardiac tamponade Left/Right heart failureLeft/Right heart failure
PEEP > 10mmHgPEEP > 10mmHg
Pulmonary embolusPulmonary embolus
Conditions that Increase PCWPConditions that Increase PCWP
ARDSARDS
COPDCOPD
Pulmonary embolusPulmonary embolus PEEP > 10mmHgPEEP > 10mmHg
Mitral valve diseaseMitral valve disease
Aortic valve diseaseAortic valve disease
Diastolic dysfunctionDiastolic dysfunction
Tension pneumothoraxTension pneumothorax Vasopressor therapyVasopressor therapy
Severe abdominal distensionSevere abdominal distension
RV infarct with fluid overloadRV infarct with fluid overload
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
15/32
1414
PAC waveformsPAC waveforms
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
16/32
1515
PCWP WaveformPCWP Waveform
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
17/32
1616
PCWP MeasurementPCWP Measurement
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
18/32
1717
Placement of PulmonaryPlacement of Pulmonary
Artery CatheterArtery CatheterInsertion siteInsertion site RA distance (cm)RA distance (cm) RV distance (cm)RV distance (cm) PA distance (cm)PA distance (cm)
Right IJRight IJ 1515 25 25 40 40
Left IJLeft IJ 2020 30 30 45 45
RightSCVRightSCV 1010--1515 20 20--2525 35 35--4040
LeftSCVLeftSCV 1515 25 25 40 40
FemoralFemoral 4545--5050 55 55--6060 7070--7575
Direct catheter medially from Right IJ and LeftSCV locationsDirect catheter medially from Right IJ and LeftSCV locations
Direct catheter inferiorly from RightSCV location (may need to rotate catheter counterDirect catheter inferiorly from RightSCV location (may need to rotate catheter counter--clockwise once RV is reached)clockwise once RV is reached)
Direct catheter posteriorly from femoral vein locations and rotate catheter counterDirect catheter posteriorly from femoral vein locations and rotate catheter counter--
clockwise once RV is reachedclockwise once RV is reached
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
19/32
1818
West Zones of the LungWest Zones of the Lung
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
20/32
1919
PAC VideoPAC Video
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
21/32
2020
Normal Hemodynamic ValuesNormal Hemodynamic Values
LocationLocation NormalNormal
(mmHg)(mmHg)
Conditions increasingConditions increasing ConditionsConditions
decreasingdecreasing
RARA 22--66 Pulmonary edema, Any valvular disease, cardiacPulmonary edema, Any valvular disease, cardiacischemia, pulmonary HTN, ARDS, sepsis, RVischemia, pulmonary HTN, ARDS, sepsis, RV
infarct, cardiac tamponade, restrictiveinfarct, cardiac tamponade, restrictive
cardiomyopathy (CMP), PEEP>10cardiomyopathy (CMP), PEEP>10
HypovolemiaHypovolemia
RVRV 1515--25/25/33--77
Everything that increases RAP (exceptEverything that increases RAP (excepttamponade) and ASD and VSDtamponade) and ASD and VSD Hypovolemia, TSHypovolemia, TSand tamponadeand tamponade
PAPA 2020--30/30/
55--1515
PE, COPD, ARDS, sepsis, pulmonary HTN,PE, COPD, ARDS, sepsis, pulmonary HTN,
restrictive CMP, ASD, VSD, pulmonary edema,restrictive CMP, ASD, VSD, pulmonary edema,
MV/AV disease, diastolic dysfunction, cardiacMV/AV disease, diastolic dysfunction, cardiac
tamponade, HR > 125tamponade, HR > 125
Hypovolemia, TSHypovolemia, TS
and PSand PS
PCWPPCWP 88--1212 ARDS, sepsis, pulmonary HTN, COPD, PE,ARDS, sepsis, pulmonary HTN, COPD, PE,restrictive CMP, cardiac ischemia, volumerestrictive CMP, cardiac ischemia, volume
overload, MV/AV disease, diastolic dysfunction,overload, MV/AV disease, diastolic dysfunction,
cardiac tamponade, HR > 125, PEEP> 10, Westcardiac tamponade, HR > 125, PEEP> 10, West
Zone I/II placementZone I/II placement
Hypovolemia, AI,Hypovolemia, AI,
PI andPI and
pneumonectomypneumonectomy
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
22/32
2121
Overwedged PACOverwedged PAC
Cant inflate the full balloon without resistanceCant inflate the full balloon without resistance
Rising PCWP baseline when balloon is inflatedRising PCWP baseline when balloon is inflated
Wedged waveform seen with the balloon downWedged waveform seen with the balloon down
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
23/32
2222
Evaluation of Shock StatesEvaluation of Shock StatesShock typeShock type PCWP PCWP Cardiac index Cardiac index
(CI)(CI)
Systemic vascularSystemic vascular
resistance index (SVRI)resistance index (SVRI)
CardiogenicCardiogenic
(CI < 2.0L/min.)(CI < 2.0L/min.) HypovolemicHypovolemic DistributiveDistributive (sepsis,(sepsis,
acute pancreatitis,acute pancreatitis,
anaphylactic oranaphylactic or
neurogenic)neurogenic)
NormalNormal
Elevated (unlessElevated (unless
SIRSSIRS--relatedrelated
myocardialmyocardial
dysfxn)dysfxn)
ObstructiveObstructive (tension(tension
PTX, massive PEPTX, massive PEoror
tamponade*tamponade* (tamponade)(tamponade)NL/NL/ (PE)(PE)
**-- tamponade will show equalization of RA, RV and PAD pressurestamponade will show equalization of RA, RV and PAD pressures
-- Massive PE associated with elevated PA, RA and CVP pressures, PAD>PCWP, profoundMassive PE associated with elevated PA, RA and CVP pressures, PAD>PCWP, profound
hypoxemia and right heart strain on EKGhypoxemia and right heart strain on EKG
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
24/32
KumarA et al. Crit Care Med. 2004; 32: 691KumarA et al. Crit Care Med. 2004; 32: 691--9.9. 2323
Optimizing PreloadOptimizing Preload
Determine the optimal PCWP by calculating CI atDetermine the optimal PCWP by calculating CI atdifferent PCWPdifferent PCWP
Calculate the patients FrankCalculate the patients Frank--Starling CurveStarling Curve
Neither the initial CVP nor the initial PCWP valueNeither the initial CVP nor the initial PCWP valueaccurately predicts the CI response to fluidsaccurately predicts the CI response to fluids
Clues to hypovolemiaClues to hypovolemia
Drop in CVP when patient takes a spontaneous breathDrop in CVP when patient takes a spontaneous breath
Marked change in SaOMarked change in SaO22waveform during respirationwaveform during respiration
Fall in SBP during inspiration with positive pressureFall in SBP during inspiration with positive pressureventilationventilation
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
25/32
2424
Mixed Venous Oxygen SaturationMixed Venous Oxygen Saturation
SvOSvO22 is the oxygen saturation returning to the right heartis the oxygen saturation returning to the right heart
Determinants ofSvODeterminants ofSvO22 Oxygen deliveryOxygen delivery
Oxygen extractionOxygen extraction
High values indicate (70%):High values indicate (70%):
Adequate tissue perfusionAdequate tissue perfusion
Poor tissue extraction of oxygenPoor tissue extraction of oxygen
Desired values in shockDesired values in shock
SvOSvO2270%70%
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
26/32
N Engl J Med. 2001; 345: 1368N Engl J Med. 2001; 345: 1368--7777 2525
EarlyEarly--Goal Directed TherapyGoal Directed Therapy
in Septic Shockin Septic Shock
Assure SaOAssure SaO22 92% or PaO26092% or PaO260
Crystalloiduntil CVP8Crystalloiduntil CVP8--12mmHg or PCWP1212mmHg or PCWP12--15mmHg15mmHg
If MAP
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
27/32
2626
Management of Shock StatesManagement of Shock States
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
28/32
Crit Care Med. 2001; 29: 1081Crit Care Med. 2001; 29: 1081 2727
Right Ventricular EndRight Ventricular End--
Diastolic Volume IndexDiastolic Volume Index
Right ventricular endRight ventricular end--diastolic volume index (RVEDVI)diastolic volume index (RVEDVI)
Volumetric measurementVolumetric measurement
Calculated from SVICalculated from SVI
More reliable than CVP or PCWP as a predictor ofMore reliable than CVP or PCWP as a predictor ofpreload status in shock and response to fluidspreload status in shock and response to fluids
Linear improvement of CI when RVEDVILinear improvement of CI when RVEDVI 70to 10070to 100--140140
Unreliable with severe TRUnreliable with severe TR
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
29/32
2828
VasopressorsVasopressors
Pure Alpha P ure BetaBeta actionAlpha = Beta
High dose Dopamine Low dose
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
30/32
2929
MedicationMedication ReceptorsReceptors Inotropy Inotropy Chronotropy Chronotropy DoseDose
DopamineDopamine
Dopamine rr.Dopamine rr.
= =
> >
Vasodilation effectVasodilation effect
Yes YesYes Yes
Vasoconstriction effectVasoconstriction effect
5mcg/kg/min 5mcg/kg/min
55--10mcg/kg/min10mcg/kg/min
> 10mcg/kg/min> 10mcg/kg/min
DobutamineDobutamine 11 and and 22>> YesYes YesYes 2.52.5-- 20mcg/kg/min20mcg/kg/minNorepinephrineNorepinephrine
(Levophed)(Levophed) > > YesYes + / + /--
0.030.03 1.51.5
mcg/kg/min.mcg/kg/min.
VasopressinVasopressin
(adjunct)(adjunct)
V1 / V2V1 / V2
receptorsreceptors
VasoconstrictionVasoconstriction
Augments catecholaminesAugments catecholamines0.010.01-- 0.04units/min0.04units/min
PhenylephrinePhenylephrine(Neosynephrine)(Neosynephrine) VasoconstrictionVasoconstriction 0.50.5-- 8mcg/kg/min.8mcg/kg/min.
IsoproterenolIsoproterenol P ure agonistPure agonistYesYes YesYes
22--10mcg/min10mcg/minMild vasodilationMild vasodilation
InotropesInotropes
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
31/32
3030
Misc. Information for PACMisc. Information for PAC
WWW.PACEP.ORGWWW.PACEP.ORG
CodingCoding
9350393503 Insertion and placement of flowInsertion and placement of flow--directeddirected
catheter for monitoring purposescatheter for monitoring purposes
-
8/6/2019 PAC and Hemodynamic Monitoring 2-4-08
32/32